N-(3-(2-phenylhydrazinecarbonyl)-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-ylcarbamoyl)benzenesulfonamide

ID: ALA574217

PubChem CID: 45112455

Max Phase: Preclinical

Molecular Formula: C23H24N4O4S2

Molecular Weight: 484.60

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(Nc1sc2c(c1C(=O)NNc1ccccc1)CCCCC2)NS(=O)(=O)c1ccccc1

Standard InChI:  InChI=1S/C23H24N4O4S2/c28-21(26-25-16-10-4-1-5-11-16)20-18-14-8-3-9-15-19(18)32-22(20)24-23(29)27-33(30,31)17-12-6-2-7-13-17/h1-2,4-7,10-13,25H,3,8-9,14-15H2,(H,26,28)(H2,24,27,29)

Standard InChI Key:  WWQYCYSNJIRQOD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
    8.0108    0.7849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7554    1.1313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8181   -0.0192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3269   -0.6704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1529   -0.6762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4947    0.7611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6751   -0.0391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4919   -0.1148    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   10.8163    0.6386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2004    1.1799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6406    0.6418    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.0565   -0.0707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8815   -0.0667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.6474   -0.7871    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.2974   -0.7792    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   14.1224   -0.7753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5364   -1.4899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3607   -1.4863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7706   -0.7693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3502   -0.0545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5274   -0.0616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5953   -1.2192    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.7042   -1.4917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.1792    2.0046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8828    2.4354    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4543    2.3986    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7507    1.9678    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0258    2.3618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0082    3.1869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2842    3.5808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5796    3.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6036    2.3210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3281    1.9309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 15 16  1  0
  3  4  1  0
 16 17  2  0
  2  6  1  0
 17 18  1  0
  7  8  1  0
 18 19  2  0
  8  9  1  0
 19 20  1  0
  9 10  2  0
 20 21  2  0
 21 16  1  0
 10  6  1  0
 15 22  2  0
  7  5  1  0
 15 23  2  0
  9 11  1  0
 10 24  1  0
  4  5  1  0
 24 25  2  0
 11 12  1  0
 24 26  1  0
  6  7  2  0
 26 27  1  0
 12 13  1  0
 27 28  1  0
 28 29  2  0
 12 14  2  0
 29 30  1  0
  1  3  1  0
 30 31  2  0
 13 15  1  0
 31 32  1  0
  1  2  1  0
 32 33  2  0
 33 28  1  0
M  END

Associated Targets(Human)

HCC 2998 (41480 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-3 (48710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NSCLC (640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leukemia cell (223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Melanoma cell (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EKVX (44102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-257 (46019 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 484.60Molecular Weight (Monoisotopic): 484.1239AlogP: 4.28#Rotatable Bonds: 6
Polar Surface Area: 116.40Molecular Species: ACIDHBA: 6HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 3.57CX Basic pKa: CX LogP: 6.05CX LogD: 5.11
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.31Np Likeness Score: -1.87

References

1. El-Sherbeny MA, Abdel-Aziz AA, Ahmed MA..  (2010)  Synthesis and antitumor evaluation of novel diarylsulfonylurea derivatives: molecular modeling applications.,  45  (2): [PMID:19939520] [10.1016/j.ejmech.2009.11.014]

Source